- Home
- EDSA vs CDIO Comparison
EDSA vs CDIO Comparison
Compare EDSA & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- CDIO
- Stock Information
- Founded
- EDSA 2015
- CDIO 2017
- Country
- EDSA Canada
- CDIO United States
- Employees
- EDSA N/A
- CDIO N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- Sector
- EDSA Health Care
- CDIO Health Care
- Exchange
- EDSA Nasdaq
- CDIO Nasdaq
- Market Cap
- EDSA 11.0M
- CDIO 12.4M
- IPO Year
- EDSA N/A
- CDIO N/A
- Fundamental
- Price
- EDSA $2.09
- CDIO $0.26
- Analyst Decision
- EDSA Strong Buy
- CDIO Buy
- Analyst Count
- EDSA 1
- CDIO 1
- Target Price
- EDSA $21.00
- CDIO $2.00
- AVG Volume (30 Days)
- EDSA 50.3K
- CDIO 5.5M
- Earning Date
- EDSA 12-13-2024
- CDIO 11-13-2024
- Dividend Yield
- EDSA N/A
- CDIO N/A
- EPS Growth
- EDSA N/A
- CDIO N/A
- EPS
- EDSA N/A
- CDIO N/A
- Revenue
- EDSA N/A
- CDIO $35,688.00
- Revenue This Year
- EDSA N/A
- CDIO $2,093.61
- Revenue Next Year
- EDSA N/A
- CDIO $43.05
- P/E Ratio
- EDSA N/A
- CDIO N/A
- Revenue Growth
- EDSA N/A
- CDIO 180.90
- 52 Week Low
- EDSA $2.09
- CDIO $0.19
- 52 Week High
- EDSA $6.46
- CDIO $3.56
- Technical
- Relative Strength Index (RSI)
- EDSA 19.32
- CDIO 44.89
- Support Level
- EDSA $2.26
- CDIO $0.21
- Resistance Level
- EDSA $2.44
- CDIO $0.52
- Average True Range (ATR)
- EDSA 0.26
- CDIO 0.07
- MACD
- EDSA -0.06
- CDIO -0.00
- Stochastic Oscillator
- EDSA 0.00
- CDIO 13.03
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assistance in the treatment of cardiovascular disease.